Document is current
Any future updates will be listed below
-
Authors
Saddal, Shalina R. D. https://orcid.org/0000-0001-7824-2796
van der Hiele, Karin
Motazedi, Ehsan
van Egmond, Elianne E. A.
Visser, Leo H.
Waskowiak, Pauline T.
van der Kruit, Amber
van Dam, Maureen
Schoonheim, Menno M.
de Groot, Vincent
Hulst, Hanneke E.
Schaafsma, Frederieke G.
-
Funding
Funding for this research was provided by:
ZonMw (842003003)
TeVa pharmaceutical industries
Nationaal MS Fonds
Celgene
Bristol-Myers Squibb
- License Information
-
More Information
Article History
Accepted: 11 February 2025
First Online: 27 February 2025
Declarations
:
: S.R.D. Saddal, K. van der Hiele, E. Motazedi, E.E.A. van Egmond, L.H. Visser, A. van der Kruit, M.M. Schoonheim, V. de Groot & F.G. Schaafsma declare no conflicts of interest. P.T. Waskowiak has served as a speaker for and received research support from Biogen. M.v.D. was supported by a research grant from BMS. H. E. Hulst is an editor of the Multiple Sclerosis Journal controversies sections, receives research support from the Dutch MS Research Foundation and the Dutch Research Council. She has served as a consultant for or received research support from Atara Biotherapeutics, Biogen, Novartis, Celgene/Bristol Meyers Squibb, Sanofi Genzyme, MedDay and Merck BV.
: Temprano was approved by the Medical Ethics Committee of Amsterdam UMC (Register CCMO: NL72064.029.20). The MS@Work study was approved by the Medical Ethical Committee Brabant (Register CCMO: NL43098.008.12 1307).
: All included participants from the Temprano study signed informed consent agreeing to use of their data to research what happens early after MS diagnosis. All included participants from the MS@Work study signed informed consent agreeing to use their data for the purpose of investigating which (possibly treatable) factors lead to decreased work or job loss in pwMS.
: Not applicable.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
